Budesonide Glycopyr Formoterol

Asthma & Respiratory

Save $1,732/mo

200× cheaper

A three-drug inhaler (budesonide, glycopyrrolate, and formoterol) used for the maintenance treatment of COPD.

United States

$1,741

per month

India

per month

You save

$1,732

99.50% cheaper in India

1.4M US scripts/yr$2.5B potential annual savings$2.5B US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

US price$1,741per month

India price$9per month

You save$1,73299.50% less

Based on 30 units per month. US $58.03 vs India $0.29 per unit.

How many months / courses?

Total over 1 periodSave $1,732$1,741 → $9

Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Months of medicine

Round-trip flights ($)

Hotel / night ($)

Nights of stay

Extra buffer ($)

Medicine savings over 6 months: $10,393
Estimated travel cost: − $2,300
Net savings after travel: $8,093

Even after travel, you could come out ahead by about $8,093.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Budesonide Glycopyr Formoterol is filled about 1.4M times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$2.5B

If sourced from India

$12.5M

Potential annual savings

$2.5B

−100%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.